These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 36524130)
1. Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma. Qian C; Jiang Z; Zhou T; Wu T; Zhang Y; Huang J; Ouyang J; Dong Z; Wu G; Cao J Front Immunol; 2022; 13():1034992. PubMed ID: 36524130 [TBL] [Abstract][Full Text] [Related]
2. Vesicle-mediated transport-related genes predict the prognosis and immune microenvironment in hepatocellular carcinoma. Ye Z; Wang Y; Yuan R; Ding R; Hou Y; Qian L; Zhang S J Cancer; 2024; 15(12):3645-3662. PubMed ID: 38911369 [No Abstract] [Full Text] [Related]
3. Significance of Spliceosome-Related Genes in the Prediction of Prognosis and Treatment Strategies for Lung Adenocarcinoma. Yang Y; Huang T; Fan Y; Lu H; Shao J; Wang Y; Shen A Biomed Res Int; 2022; 2022():1753563. PubMed ID: 36389112 [TBL] [Abstract][Full Text] [Related]
4. A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma. Liang JX; Chen Q; Gao W; Chen D; Qian XY; Bi JQ; Lin XC; Han BB; Liu JS BMC Bioinformatics; 2022 Dec; 23(1):562. PubMed ID: 36575396 [TBL] [Abstract][Full Text] [Related]
5. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis. Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J Front Immunol; 2022; 13():783495. PubMed ID: 35222371 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of immune escape-related genes in lung adenocarcinoma. Jia HR; Li WC; Wu L Transl Cancer Res; 2024 Jun; 13(6):2647-2661. PubMed ID: 38988926 [TBL] [Abstract][Full Text] [Related]
7. Integrated multi-omic analysis and experiment reveals the role of endoplasmic reticulum stress in lung adenocarcinoma. Liu Y; Lin W; Qian H; Yang Y; Zhou X; Wu C; Pan X; Liu Y; Wang G BMC Med Genomics; 2024 Jan; 17(1):12. PubMed ID: 38167084 [TBL] [Abstract][Full Text] [Related]
8. Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay. Liang H; Li Y; Qu Y; Zhang L Oncol Res; 2023; 32(2):393-407. PubMed ID: 38186574 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosis. Jiang Y; Hammad B; Huang H; Zhang C; Xiao B; Liu L; Liu Q; Liang H; Zhao Z; Gao Y Transl Lung Cancer Res; 2024 Jun; 13(6):1277-1295. PubMed ID: 38973963 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma. Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226 [TBL] [Abstract][Full Text] [Related]
11. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J Front Immunol; 2023; 14():1217590. PubMed ID: 37492563 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma. Wu X; Zhao X; Zhou C; Wei N; Xu Z; Zhang X J Cancer Res Clin Oncol; 2024 Apr; 150(4):188. PubMed ID: 38602568 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma. Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y Front Immunol; 2022; 13():950001. PubMed ID: 36091041 [TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes. Li F; Niu Y; Zhao W; Yan C; Qi Y Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857 [TBL] [Abstract][Full Text] [Related]
15. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma. Xu Z; Chen C Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102 [TBL] [Abstract][Full Text] [Related]
16. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns. Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675 [TBL] [Abstract][Full Text] [Related]
17. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches. Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S PeerJ; 2023; 11():e16166. PubMed ID: 37790630 [TBL] [Abstract][Full Text] [Related]
18. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma. Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ Front Genet; 2022; 13():1017866. PubMed ID: 36699466 [No Abstract] [Full Text] [Related]
20. Development and Validation of a Machine Learning Prognostic Model of m5C Related immune Genes in Lung Adenocarcinoma. Cao X; Ji Y; Li J; Liu Z; Chen C Cancer Control; 2024; 31():10732748241237414. PubMed ID: 38537151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]